Navigation Links
US Oncology Launches New Services Division: Innovent Oncology
Date:9/2/2008

riation in treatment selection, side effects that prompt ER visits and hospitalizations, and ineffective interventions near the end of life.

The core services offered include:

-- Level I Pathways: Physician-developed, evidence-based pathways that reduce treatment variability and resulting costs while providing a platform for standardization, outcomes measurement and ongoing peer review.

-- Patient Support Services: An oncology-specific disease management program that increases treatment compliance, helps patients monitor and manage side effects, and reduces unnecessary ER visits and hospitalizations.

-- Advance Care Planning: Transition care planning and implementation that prepares patients early in their care process for potential end-of-life issues by addressing clinical, social, financial and spiritual needs.

Innovent Oncology serves as the nexus between provider and payer. It bundles the core services and offers them to health plans on a per participant basis. By integrating these services, payers benefit from the valuable insight available through enhanced data capture and analysis, outcomes measurement and utilization review. The integrated approach increases efficiency and aligns payer and provider financial incentives.

Innovent Oncology supports oncologists, both outside and within the US Oncology network of member practices, by providing access to clinical decision making tools and enhanced patient support and education. Physicians connect to the program via an internet portal where summary diagnoses, staging and line-of-therapy data can be submitted to determine appropriate Level I Pathways evidence-based treatment guidelines. The portal is also used to enroll patients in the Patient Support Services program. In addition to gaining access to cancer treatment tools and resources that benefit their patients, participating physicians also receive compensation for voluntary compliance with Level I Pathways and utiliza
'/>"/>

SOURCE US Oncology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... did it make you feel? According to psychologists, remembering ... as how sad you were or how embarrassed you ... can,t stop thinking about it. , When these ... the memories, rather than how you felt, is a ... effects of these memories, a new study suggests. , ...
(Date:4/18/2014)... A discovery by Northwestern Medicine scientists could lead to ... scarring in people with scleroderma. , Fibrosis, or ... tightening of the skin and lungs can lead to ... The concept for new therapeutic options centers on findings ... Medicine-Rheumatology, who identified the role that a specific protein ...
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... MANHASSET, NY In a review published in the ... MD, president of The Feinstein Institute for Medical Research, ... the medical community,s approach to treating sepsis, ... 200,000 Americans. , Sepsis occurs when molecules released into ... inflammation throughout the body. Inflammation is necessary for maintaining ...
(Date:4/17/2014)... million older Americans suffer from depression, often brought on ... research a project that followed the lives of ... found that Internet use among the elderly can reduce ... , "That,s a very strong effect," said Shelia Cotten, ... and media who led the project. "And it all ...
Breaking Medicine News(10 mins):Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Internet use can help ward off depression among elderly 2
... Case Studies in the Management of PK/PD Data Will be Presented ... ... France, MOUNTAIN VIEW, Calif., Sept. 25 Pharsight,Corporation (OTC ... optimizing clinical drug development, today,announced that Dan Weiner, Ph.D., Senior Vice ...
... Call it Quits collaborative launches new Minnesota Clinic Fax Referral ... ... 25 Call it Quits,-- a newly named collaboration among Minnesota,s major ... it easier,for physicians and other healthcare providers to help their patients who,want ...
... the Cure(TM) Kicks Off October 1; Join the Breast ... Cancer Movement by Wearing Pink In October, DALLAS, Sept. ... together to increase awareness of breast cancer,a disease that without a ... you can join them. (Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO ) The ...
... Australian researcher has completed some pioneering work which is ... , Professor Patrick Tams 27-year exploration has mapped ... embryos. It reveals how cells direct themselves to ... He was (today) awarded recognition at a national conference ...
... PGL; Nasdaq: PGLA) announced today that its investigational,anti-cancer ... by the U.S. Food,and Drug Administration (FDA). The ... for the prevention of tumor recurrence following curative ... liver,cancer). Under the FDA Modernization Act of ...
... ARBOR, Mich. -- Despite decades of advances in diabetes ... likely than whites to have their blood sugar under ... nationally representative study finds. That puts them at a ... foot amputation and other long-term diabetes complications. , ...
Cached Medicine News:Health News:Pharsight to Host European Software Conference 2Health News:Health Organizations Join Forces Around Quit-Smoking Help 2Health News:Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure 2Health News:Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure 3Health News:Explorer completes the map ... for the body's blueprint 2Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 2Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 3Health News:Older blacks and Latinos still lag whites in controlling diabetes 2Health News:Older blacks and Latinos still lag whites in controlling diabetes 3Health News:Older blacks and Latinos still lag whites in controlling diabetes 4Health News:Older blacks and Latinos still lag whites in controlling diabetes 5
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements ... announced tender offer by its indirect wholly-owned subsidiary, Sapphire ... of common stock of Solta Medical, Inc. (NASDAQ: ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Jan. 14, 2014  Luminex Corporation (Nasdaq: LMNX ) ... fourth quarter of 2013 on Monday, February 3, 2014. A ... the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ... discuss the operating highlights and financial results for the fourth ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. For newly born children. 10 mm internal diameter of the cornea ...
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. The classic Goldmann Glass....
For the binocular slit observation of the pupil, the macula, its surroundings out to 30 as well as the central vitreous body sections. Easy to use, lightweight glass provides a direct image....
... philosophy of the Quad 4™ Intramedullary Nailing ... that could be used for the widest ... of the system were to minimize the ... inventory, with one system that could address ...
Medicine Products: